Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Exane BNP Paribas Downgrades Buzzi Unicem to Neutral

Exane BNP Paribas downgrades Buzzi Unicem (OTC:BZZUY) from Outperform to Neutral.

byBenzinga Newsdesk

September 9, 2021

1 minute read

Exane BNP Paribas downgrades Buzzi Unicem (OTC:BZZUY) from Outperform to Neutral.

Needham Maintains Buy on Alnylam Pharmaceuticals, Raises Price Target to $205

By Benzinga Newsdesk

Today, 3:05 AM

Needham analyst Joseph Stringer maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and raises the price target from $180 to $205.

ALNY

Volatility In Markets Increases Sharply Ahead Of Inflation Data, Fed’s Rate Decision

By Lisa Levin

Today, 3:05 AM

US stocks closed sharply higher on Monday, ahead of the much-awaited inflation data and interest rate decision from the Federal Reserve. Economists project the US central bank, and the European Central Bank and Bank of England to all increase interest rates by 50 basis points.

AAPL